CN104876899A - Dimethylamino sphaelactone fumarate and use thereof - Google Patents
Dimethylamino sphaelactone fumarate and use thereof Download PDFInfo
- Publication number
- CN104876899A CN104876899A CN201410071673.6A CN201410071673A CN104876899A CN 104876899 A CN104876899 A CN 104876899A CN 201410071673 A CN201410071673 A CN 201410071673A CN 104876899 A CN104876899 A CN 104876899A
- Authority
- CN
- China
- Prior art keywords
- cancer
- carcinoma
- formula
- compound
- fumarate
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The invention relates to a compound represented by formula (I), that is, dimethylamino sphaelactone fumarate, and a use thereof. The compound of formula (I) has the advantages of high stability and low hygroscopicity.
Description
Technical field
The invention belongs to technical field of pharmaceuticals, be specifically related to dimethylamine and have a smile on one's face lactone fumarate and uses thereof.
Background technology
Document (J. Med. Chem. 2012,55,8757 8769) in, report formula II compound is used for the treatment of leukemia, but further research find formula II compound exist unstable, draw the moist defect such as seriously, limit its further medicament research and development.
(Ⅱ)
Compound provided by the invention overcome formula II compound exist unstable, draw the moist defect such as seriously, have stability high, draw moist low advantage.
Summary of the invention
The invention provides formula I compound, dimethylamine has a smile on one's face lactone fumarate and uses thereof.
(Ⅰ)
Described formula I compound is being used for the treatment of the purposes in cancer.Wherein said cancer comprises acute myeloid leukemia, chronic myelogenous leukemia, chronic lymphocytic leukemia, skin carcinoma, mammary cancer, ovarian cancer, cerebral tumor, prostate cancer, head and neck scale carcinoma, laryngocarcinoma, carcinoma of the pancreas, retinoblastoma cell cancer, children liver parent cell cancer, liver cancer, melanoma, large bowel cancer, adenocarcinoma of colon, glioma, esophagus cancer, nasopharyngeal carcinoma, cerebral glioma, cancer of the stomach, lung cancer, kidney, bladder cancer, thyroid carcinoma.
Embodiment
In order to understand the present invention, further illustrate the present invention with embodiment below, but do not limit the present invention.
embodiment 1 dimethylamine has a smile on one's face the preparation of lactone fumarate
To in the 250mL round-bottomed flask being equipped with mechanical stirring, thermometer, reflux condensing tube, add fumaric acid (1.98g, 17mmol), ethyl acetate (2.5 mL), stir, be heated to 77 DEG C; Dimethylin being had a smile on one's face lactone (5.0g, 17mmol) mixes with ethyl acetate (15 mL), drops in the middle of reaction, vigorous stirring; After dropwising, reaction solution was in 77 DEG C of insulations 3 hours; Stop heating, under whipped state, be naturally down to room temperature, filter, ethyl acetate is washed, and vacuum-drying 24 hours, namely obtains formula (I) compound, white solid 6.3g, yield 90%.
Prepare the data of formula (I) compound:
Molecular formula: C
21h
31nO
7
Molecular weight: 409
Proterties: white solid powder
Elemental analysis data:
Element | Calculated value/% | Test value/% |
C | 61.60 | 61.41 |
H | 7.63 | 7.37 |
N | 3.42 | 3.54 |
Nuclear magnetic resonance data (NMR):
1H NMR (DMSO, 500 MHz)6.58 (s, 2H), 3.80 (t , J = 10.3 Hz, 1H ), 2.64(s, 3H), 2.49-2.53 (m, 3H), 2.26-2.27 (m, 1H), 2.23 (s, 6H), 1.96-2.10 (m, 6H),1.60 (s, 3H), 1.57-1.59 (m, 2H), 1.23-1.25 (m, 1H), 1.15 (s, 3H);
13C NMR(DMSO, 125 MHz)177.8, 167.6(2C), 135.2(2C), 133.7, 131.4, 83.4, 80.31, 58.0, 57.1, 51.7, 45.2(2C), 43.6, 41.0, 35.3, 30.2, 27.0, 24.2, 23.2.
High resolution mass spectrum data (HRMS): [C
17h
27nO
3+ H
+]: calculated value, 294.2064; Test value, 294.2067.
embodiment 2 dimethylamine have a smile on one's face lactone fumarate pharmacological action
Various cancer cells is made into 2 × 10
5/ mL cell suspension, add in 24 orifice plate round bottom Tissue Culture Plates, add test compounds respectively, every test concentrations 5 hole, put 37 degree, 5% carbonic acid gas saturated humidity regulates lower cultivation 18 hours, records absorbancy and refers to, calculate the restraining effect of the compounds of this invention to test cancer cells with mtt assay at enzyme connection detector 570nm wavelength.
Table 1 formula I compound is to the restraining effect of various cancer cells
Clone | Formula I compound |
HL-60 | 31.5 |
K562 | 22.3 |
MCF-7 | 19.5 |
CNE-1 | 26.3 |
CNE-2 | 26.5 |
SW620 | 33.4 |
A549 | 28.3 |
HepG-2 | 17.7 |
Ec9706 | 23.2 |
SGC7901 | 14.7 |
SW1116 | 37.1 |
A498 | 24.1 |
ASPC-1 | 31.5 |
HT-29 | 19.2 |
HeLa | 29.4 |
GL15 | 45.2 |
B16F1 | 28.3 |
T24 | 32.4 |
SKOV3 | 25.5 |
SW579 | 42.3 |
PC-3 | 33.4 |
HL-60, K562, MCF-7, CNE-1, CNE-2 in table 1, SW620, A549, HepG2, Ec9706, SGC7901, SW1116, A498, ASPC-1, HT-29, HeLa, GL15, B16F1, T24, SKOV3, SW579, PC-3, represent acute myeloid leukemia respectively, chronic myelogenous leukemia, mammary cancer, nasopharyngeal carcinoma, colorectal carcinoma, lung cancer, liver cancer, the esophageal carcinoma, cancer of the stomach, colorectal carcinoma, carcinoma of the pancreas, prostate cancer, colorectal carcinoma, cervical cancer, neuroblastoma, melanoma, bladder cancer, ovarian cancer, thyroid tumor, prostate cancer.
embodiment 3 formula I compound compares with the stability of formula II compound
1. high temperature test
Get formula I compound and formula II compound is put in open container, in the thermostat container of 60 DEG C, place 10 days, in sampling in 0 day, 5 days, 10 days, observe proterties, measure content.
Table 2 high temperature test result (60 DEG C)
2. high wet test
Get formula I compound and formula II compound is put in open container, be placed on relative humidity 90 ± 5%(saltpetre saturated solution) encloses container in, place 10 days, in 0 day, 5 days, 10 days sampling, observe proterties, measure content.
Table 3 high humidity test-results (90 ± 5%)
Result shows: no matter under high temperature or super-humid conditions, formula I compound is all more stable than formula II compound.
embodiment 4 formula I compound draws moist comparison with formula II compound
Table 4 draws moist comparison
Formula I compound | Formula II compound | |
Draw moist | 0.5% | 15.6% |
Result shows: drawing of formula I compound is moist moist lower than drawing of (II) compound.
Purposes of the present invention and method are described by specific embodiment.Those skilled in the art can use for reference the links such as content appropriate change raw material of the present invention, processing condition and realize other object corresponding, its relevant change does not all depart from content of the present invention, all similar replacements and change will become apparent to those skilled in the art that and be all deemed to be included within scope of the present invention.
Claims (2)
1. dimethyl amine has a smile on one's face the form of fumarate of lactone, formula I compound.
2. (I) is being used for the treatment of the purposes in cancer, and described cancer comprises acute myeloid leukemia, chronic myelogenous leukemia, chronic lymphocytic leukemia, skin carcinoma, mammary cancer, ovarian cancer, cerebral tumor, prostate cancer, head and neck scale carcinoma, laryngocarcinoma, carcinoma of the pancreas, retinoblastoma cell cancer, children liver parent cell cancer, liver cancer, melanoma, large bowel cancer, adenocarcinoma of colon, glioma, esophagus cancer, nasopharyngeal carcinoma, cerebral glioma, cancer of the stomach, lung cancer, kidney, bladder cancer, thyroid carcinoma.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410071673.6A CN104876899A (en) | 2014-02-28 | 2014-02-28 | Dimethylamino sphaelactone fumarate and use thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410071673.6A CN104876899A (en) | 2014-02-28 | 2014-02-28 | Dimethylamino sphaelactone fumarate and use thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
CN104876899A true CN104876899A (en) | 2015-09-02 |
Family
ID=53944613
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201410071673.6A Pending CN104876899A (en) | 2014-02-28 | 2014-02-28 | Dimethylamino sphaelactone fumarate and use thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN104876899A (en) |
Cited By (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105726520A (en) * | 2016-02-02 | 2016-07-06 | 南开大学 | Sphaelactone dimethylamine lipidosome atomizing inhalant and application thereof |
WO2017128163A1 (en) * | 2016-01-28 | 2017-08-03 | 天津国际生物医药联合研究院 | Application of dimethylamino micheliolide |
CN108484550A (en) * | 2018-05-07 | 2018-09-04 | 中国人民解放军第四军医大学 | One kind having a smile on one's face lactone derivatives and its preparation method and application |
CN109276553A (en) * | 2017-07-21 | 2019-01-29 | 天津尚德药缘科技股份有限公司 | Dimethylamine has a smile on one's face lactone fumarate preparation, preparation method and use |
CN111303100A (en) * | 2018-12-12 | 2020-06-19 | 天津尚德药缘科技股份有限公司 | Hydrate of michelia lactone dimethylamine fumarate, preparation method and application thereof |
CN111303097A (en) * | 2018-12-12 | 2020-06-19 | 天津尚德药缘科技股份有限公司 | Crystal form C of michelia lactone fumarate dimethylamine and preparation method thereof |
CN111303099A (en) * | 2018-12-12 | 2020-06-19 | 天津尚德药缘科技股份有限公司 | Sphaelactone dimethylamine fumarate crystal form F and preparation method thereof |
CN111803489A (en) * | 2020-07-10 | 2020-10-23 | 温州医科大学附属第一医院 | Application of michelia lactone and derivatives thereof in treatment of pituitary adenoma |
CN113149946A (en) * | 2021-04-16 | 2021-07-23 | 天津大学 | Michellac dimethylamine lactone-m-hydroxybenzoate and preparation method and application thereof |
CN113200949A (en) * | 2021-04-16 | 2021-08-03 | 天津大学 | Sphaelactone-salicylate dimethylamine and preparation method and application thereof |
WO2021189343A1 (en) * | 2020-03-26 | 2021-09-30 | 天津尚德药缘科技股份有限公司 | Hydrate of dimethylaminomicheliolide fumarate and preparation method therefor and use thereof |
US11389422B2 (en) | 2018-04-13 | 2022-07-19 | The University Of Chicago | Combination of micheliolide derivatives or nanoparticles with ionizing radiation and checkpoint inhibitors for cancer therapy |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101978959A (en) * | 2010-10-18 | 2011-02-23 | 天津尚德药缘科技有限公司 | Application of sphaelactone and derivative thereof to treatment of cancers |
WO2011131103A1 (en) * | 2010-04-23 | 2011-10-27 | 天津尚德药缘科技有限公司 | Sphaelactone derivatives, their pharmaceutical compositions, preparation methods and uses |
WO2012145678A1 (en) * | 2011-04-20 | 2012-10-26 | Regents Of The University Of Minnesota | Anti-cancer and anti-inflammatory parthenolide compounds |
CN103417532A (en) * | 2012-05-16 | 2013-12-04 | 天津尚德药缘科技有限公司 | Sesquiterpene lactone compound and uses of derivative thereof in preparation of drugs |
CN103622954A (en) * | 2012-08-22 | 2014-03-12 | 龙海波 | Applications of sesquiterpene lactone compound and derivative of sesquiterpene lactone compound in treatment of diabetes |
CN103724307A (en) * | 2012-10-12 | 2014-04-16 | 天津尚德药缘科技有限公司 | Sphaelactone dimethylamine fumarate crystal form and preparation method thereof |
-
2014
- 2014-02-28 CN CN201410071673.6A patent/CN104876899A/en active Pending
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2011131103A1 (en) * | 2010-04-23 | 2011-10-27 | 天津尚德药缘科技有限公司 | Sphaelactone derivatives, their pharmaceutical compositions, preparation methods and uses |
CN101978959A (en) * | 2010-10-18 | 2011-02-23 | 天津尚德药缘科技有限公司 | Application of sphaelactone and derivative thereof to treatment of cancers |
WO2012145678A1 (en) * | 2011-04-20 | 2012-10-26 | Regents Of The University Of Minnesota | Anti-cancer and anti-inflammatory parthenolide compounds |
CN103417532A (en) * | 2012-05-16 | 2013-12-04 | 天津尚德药缘科技有限公司 | Sesquiterpene lactone compound and uses of derivative thereof in preparation of drugs |
CN103622954A (en) * | 2012-08-22 | 2014-03-12 | 龙海波 | Applications of sesquiterpene lactone compound and derivative of sesquiterpene lactone compound in treatment of diabetes |
CN103724307A (en) * | 2012-10-12 | 2014-04-16 | 天津尚德药缘科技有限公司 | Sphaelactone dimethylamine fumarate crystal form and preparation method thereof |
Non-Patent Citations (1)
Title |
---|
ZHANG, QUAN; LU, YAXIN; DING, YAHUI; 等.: "Guaianolide Sesquiterpene Lactones, a Source To Discover Agents That Selectively Inhibit Acute Myelogenous Leukemia Stern and Progenitor Cells", 《JOURNAL OF MEDICINAL CHEMISTRY》 * |
Cited By (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2016390488B9 (en) * | 2016-01-28 | 2020-09-17 | Accendatech | Application of dimethylamino micheliolide |
WO2017128163A1 (en) * | 2016-01-28 | 2017-08-03 | 天津国际生物医药联合研究院 | Application of dimethylamino micheliolide |
JP2019503335A (en) * | 2016-01-28 | 2019-02-07 | 天津国際生物医薬聯合研究院 | Use of Dimethylamino Micheliolide |
US10220019B2 (en) | 2016-01-28 | 2019-03-05 | Tianjin International Joint Academy Of Biotechnology & Medicine | Method for treating pulmonary fibrosis comprising application of dimethylamino micheliolide |
AU2016390488B2 (en) * | 2016-01-28 | 2019-12-12 | Accendatech | Application of dimethylamino micheliolide |
CN105726520B (en) * | 2016-02-02 | 2019-04-09 | 南开大学 | Lactone dimethylamine liposome atomized inhalation and its application with a smile |
CN105726520A (en) * | 2016-02-02 | 2016-07-06 | 南开大学 | Sphaelactone dimethylamine lipidosome atomizing inhalant and application thereof |
CN109276553A (en) * | 2017-07-21 | 2019-01-29 | 天津尚德药缘科技股份有限公司 | Dimethylamine has a smile on one's face lactone fumarate preparation, preparation method and use |
CN109276553B (en) * | 2017-07-21 | 2023-01-13 | 天津尚德药缘科技股份有限公司 | Preparation of michelia lactone fumarate of dimethylamine, preparation method and application thereof |
US11389422B2 (en) | 2018-04-13 | 2022-07-19 | The University Of Chicago | Combination of micheliolide derivatives or nanoparticles with ionizing radiation and checkpoint inhibitors for cancer therapy |
CN108484550A (en) * | 2018-05-07 | 2018-09-04 | 中国人民解放军第四军医大学 | One kind having a smile on one's face lactone derivatives and its preparation method and application |
CN111303099A (en) * | 2018-12-12 | 2020-06-19 | 天津尚德药缘科技股份有限公司 | Sphaelactone dimethylamine fumarate crystal form F and preparation method thereof |
CN111303097A (en) * | 2018-12-12 | 2020-06-19 | 天津尚德药缘科技股份有限公司 | Crystal form C of michelia lactone fumarate dimethylamine and preparation method thereof |
CN111303097B (en) * | 2018-12-12 | 2022-09-30 | 天津尚德药缘科技股份有限公司 | Crystal form C of michelia lactone fumarate dimethylamine and preparation method thereof |
CN111303100B (en) * | 2018-12-12 | 2022-10-04 | 天津尚德药缘科技股份有限公司 | Hydrate of michelia lactone dimethylamine fumarate, preparation method and application thereof |
CN111303099B (en) * | 2018-12-12 | 2022-12-02 | 天津尚德药缘科技股份有限公司 | Sphaelactone dimethylamine fumarate crystal form F and preparation method thereof |
CN111303100A (en) * | 2018-12-12 | 2020-06-19 | 天津尚德药缘科技股份有限公司 | Hydrate of michelia lactone dimethylamine fumarate, preparation method and application thereof |
WO2021189343A1 (en) * | 2020-03-26 | 2021-09-30 | 天津尚德药缘科技股份有限公司 | Hydrate of dimethylaminomicheliolide fumarate and preparation method therefor and use thereof |
CN111803489A (en) * | 2020-07-10 | 2020-10-23 | 温州医科大学附属第一医院 | Application of michelia lactone and derivatives thereof in treatment of pituitary adenoma |
CN113149946A (en) * | 2021-04-16 | 2021-07-23 | 天津大学 | Michellac dimethylamine lactone-m-hydroxybenzoate and preparation method and application thereof |
CN113200949A (en) * | 2021-04-16 | 2021-08-03 | 天津大学 | Sphaelactone-salicylate dimethylamine and preparation method and application thereof |
CN113200949B (en) * | 2021-04-16 | 2022-11-29 | 天津大学 | Dimethylamine michelia lactone-salicylate and preparation method and application thereof |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN104876899A (en) | Dimethylamino sphaelactone fumarate and use thereof | |
CN104072478B (en) | One 4, class naphthalene ring contains synthesis and the application thereof of the naphthalimide derivative of 1,2,3-triazole | |
CN106432190B (en) | The naphthalimide compound of one kind aminopyrimidine containing 2-, preparation method and application | |
CN104558093A (en) | C21 steroid saponin aglycone derivative as well as preparation method and application thereof in preparing anti-tumor drugs | |
CN103845315A (en) | Histone deacetylase inhibitor and preparation method and application thereof | |
CN104530021A (en) | Compounds and preparation method thereof, application of compounds in preparing antineoplastic drugs and antineoplastic drugs prepared from compounds | |
CN110041222B (en) | Thymoquinone derivative, intermediate, preparation method and application thereof | |
CN105130895B (en) | A kind of naphthalimide derivative, its preparation method and application | |
CN105130897A (en) | Nitrogen-containing sulfur substituent naphthalimide compound, preparation method and applications thereof | |
CN106946896B (en) | Furans simultaneously [2,3-d] pyrimidine -4- amine derivative | |
CN104771392A (en) | Histone deacetylase inhibitor and applications thereof | |
CN109651373A (en) | A kind of preparation method of Xi Gelieting phosphate monohydrate crystal form | |
CN103980152B (en) | Benzamide compounds with anti-tumor activity and its preparation method and application | |
CN107163028A (en) | A kind of benzamides Hedgehog inhibitor and its preparation method and application | |
CN108863860B (en) | N-substituted phenyl-3-sulfonyl aminobenzamide compound, preparation thereof and application thereof in resisting breast cancer activity | |
CN105130896B (en) | The naphthalimide derivative of a kind of substituent containing thiocarbamide, its preparation method and application | |
CN104016879B (en) | Dibenzoyl amine compound with anti-tumor activity and its preparation method and application | |
CN104356087B (en) | Nitric oxide donator type hdac inhibitor and preparation method thereof and medicinal use | |
CN104402794B (en) | A kind of 3 aryl hydrazines substituted indole ketones derivants and preparation method and application | |
CN103833766B (en) | Shore, Agra dimethylamine fumarate and the purposes in prepared by medicine thereof | |
CN102863438A (en) | N-(4-(4-(pyridine-2-radical) piperazine-1-radical) pyrimidine-2-radical) amide and salt and preparation method and application thereof | |
CN104557916A (en) | 2-substituted-beta-carboline compounds and application thereof in preparing drugs for preventing or treating tumors | |
CN104877002A (en) | C21 steroid sapogenin derivative of dihydro parazole piperazidine, and preparation method and application thereof | |
CN106432104A (en) | Adamantyl quinazoline compound, composition and application of adamantyl quinazoline compound and composition | |
CN103467320A (en) | 2,5-disubstituted cyclopentanone derivatives and applications thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20150902 |
|
RJ01 | Rejection of invention patent application after publication |